BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29499325)

  • 1. YAP promotes breast cancer metastasis by repressing growth differentiation factor-15.
    Wang T; Mao B; Cheng C; Zou Z; Gao J; Yang Y; Lei T; Qi X; Yuan Z; Xu W; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1744-1753. PubMed ID: 29499325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.
    Hoxha S; Shepard A; Troutman S; Diao H; Doherty JR; Janiszewska M; Witwicki RM; Pipkin ME; Ja WW; Kareta MS; Kissil JL
    Cancer Res; 2020 Jun; 80(12):2512-2522. PubMed ID: 32409309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP enhances autophagic flux to promote breast cancer cell survival in response to nutrient deprivation.
    Song Q; Mao B; Cheng J; Gao Y; Jiang K; Chen J; Yuan Z; Meng S
    PLoS One; 2015; 10(3):e0120790. PubMed ID: 25811979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
    Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
    J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis.
    Moore HM; Gonzalez ME; Toy KA; Cimino-Mathews A; Argani P; Kleer CG
    Breast Cancer Res Treat; 2013 Apr; 138(3):741-52. PubMed ID: 23539298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis.
    Anwar T; Arellano-Garcia C; Ropa J; Chen YC; Kim HS; Yoon E; Grigsby S; Basrur V; Nesvizhskii AI; Muntean A; Gonzalez ME; Kidwell KM; Nikolovska-Coleska Z; Kleer CG
    Nat Commun; 2018 Jul; 9(1):2801. PubMed ID: 30022044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis.
    Zeng Y; Qiu R; Yang Y; Gao T; Zheng Y; Huang W; Gao J; Zhang K; Liu R; Wang S; Hou Y; Yu W; Leng S; Feng D; Liu W; Zhang X; Wang Y
    Cell Rep; 2019 Nov; 29(6):1482-1498.e4. PubMed ID: 31693890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer.
    Lo Sardo F; Pulito C; Sacconi A; Korita E; Sudol M; Strano S; Blandino G
    Cancer Lett; 2021 Mar; 500():51-63. PubMed ID: 33296708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.
    Liu J; Ye L; Li Q; Wu X; Wang B; Ouyang Y; Yuan Z; Li J; Lin C
    J Pathol; 2018 Jan; 244(1):71-83. PubMed ID: 28991374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
    Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
    Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.
    Mahara S; Lee PL; Feng M; Tergaonkar V; Chng WJ; Yu Q
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):E3735-44. PubMed ID: 27303043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
    Lamar JM; Stern P; Liu H; Schindler JW; Jiang ZG; Hynes RO
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):E2441-50. PubMed ID: 22891335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis.
    Smith HW; Hirukawa A; Sanguin-Gendreau V; Nandi I; Dufour CR; Zuo D; Tandoc K; Leibovitch M; Singh S; Rennhack JP; Swiatnicki M; Lavoie C; Papavasiliou V; Temps C; Carragher NO; Unciti-Broceta A; Savage P; Basik M; van Hoef V; Larsson O; Cooper CL; Vargas Calderon AC; Beith J; Millar E; Selinger C; Giguère V; Park M; Harris LN; Varadan V; Andrechek ER; O'Toole SA; Topisirovic I; Muller WJ
    Nat Commun; 2019 Jul; 10(1):2901. PubMed ID: 31263101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
    Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.
    Di Agostino S; Sorrentino G; Ingallina E; Valenti F; Ferraiuolo M; Bicciato S; Piazza S; Strano S; Del Sal G; Blandino G
    EMBO Rep; 2016 Feb; 17(2):188-201. PubMed ID: 26691213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.